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Introduction: In clinical practice, patient’s diagnosis and therapeutic decisions are often dependent on the outcome of laboratory results 
which should be highly accurate and reliable. Laboratories should be obliged to participate in international external quality assessment 
schemes (EQAS) as an essential feature to evaluate laboratory performance and quality control. The aim of this study was to perform a 
critical analysis of the last 6 and half years of UK National EQAS for blood coagulation in the Department of Immunohaemotherapy of CHLC.  
Methods: In this study we compiled the analysis of all UK NEQAS blood coagulation samples received from April 2011 to December 2017 
comprising a total of 399 samples and including: Laboratory Programme (Level 1: Screening Tests; Level 2: Assays), 
Additional/Supplementary Exercises and DOAC (Direct Oral Anticoagulant) Assay Programme. In the case of FXIII samples and DOACs, results 
are from 2013 to 2017 and 2015 to 2017, respectively. The number of samples per year varied according to the test being performed. Total 
number of samples per test from 2011-2017 varied from 37 (PT/INR) to 6 (Heparin Dosage and VWF:RCo) and 5 (direct oral anticoagulants). 





























































































































Conclusion: EQAS are essential tools for the continuous 
improvement in quality standards of patient care. These periodical 
assessements allow interlaboratory comparison but, more 
importantly, they function as  a survey for procedures  performed 
daily in  laboratories  allowing the detection of systematic  errors 
that might, otherwise,  go unnoticed. 
In this study we analysed our results from 2011-2017 and, when 
applicable, outwith consensus samples were resolved promptly 
and adequately. We can conclude that our overall performance for 
the last 6 and half years was very good.  
Results: From the total number of samples analyzed (399) 
we obtained 95.5% of results within consensus (Figure 1).  
PT/INR and APTT were the tests with the highest number of 
samples 37 and 36, respectively (Figure 2A). On the contrary,  
tests like Heparin Dosage, VWF:RCo and DOACs are 
represented by a total of 6, 6 and 5 samples, respectively 
(Figure 2A).  
Results outwith consensus were observed in 8 tests, namely 
in 32% and 11% of results for tests Prot C:Act and FVII:C, 
respectively (Figure 2B). Whenever a value was outwith 
consensus, a thorough review of the test was performed to 
find the problem, so that solutions could be applied 
accordingly. As described in Table 1 most actions involved 
using new sets of reagents or calibration curves and 
sometimes even review the hole methodology. 
When applicable, we analyzed the results in each quantile (in 
a total of 260 samples) and observed that 7.7% and 8.5% of 
all samples were in quantile D/d and E/e, respectively, 
whereas the vast majority of samples could be found in 
quantiles A/a (53%) and B/b (19%) (Figure 3). 
A B 
Figure 2 – A) Total number of samples performed per test. B) Representation of values 
within and outwith consensus for each assay 
Test Resolution 
Prot C: Act 
New calibration curve, reviewed methodology, ACL TOP 
maintenance  
D-Dimer Results were biased for portuguese samples 
Clauss 
Fibrinogen 
New methodology, namely freezing and thawing procedures 
FVIII:C 
New reagents, new calibration curve, substitution of factor 
diluent 
FV:C Reviewed  methodology, substitution  of factor diluent 
Table 1- Examples of tests outwith consensus and some of the solutions applied 
to solve them   
Figure 3 – Overall percentage of results in each quantile  
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